Source: Human Reproduction. Conference titles: Annual Meeting of the European Society of Human Reproduction and Embryology. Unidades: FMRP, FCFRP
Subjects: ANTICONCEPÇÃO, DISPOSITIVOS ANTICONCEPCIONAIS FEMININOS, VASODILATAÇÃO
ABNT
FRANCESCHINI, Silvio Antonio et al. In vivo and in vitro endothelial effects of the oral contraceptive containing 2mg chlormadinone acetate/0.3 mg ethinylestradiol. Human Reproduction. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 26 maio 2024. , 2011APA
Franceschini, S. A., Vieira, C. S., Andozia, M. B., Tolloi, M. R. T., Sá, M. F. S. de, & Ferriani, R. A. (2011). In vivo and in vitro endothelial effects of the oral contraceptive containing 2mg chlormadinone acetate/0.3 mg ethinylestradiol. Human Reproduction. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Franceschini SA, Vieira CS, Andozia MB, Tolloi MRT, Sá MFS de, Ferriani RA. In vivo and in vitro endothelial effects of the oral contraceptive containing 2mg chlormadinone acetate/0.3 mg ethinylestradiol. Human Reproduction. 2011 ; 26 i247-i248.[citado 2024 maio 26 ]Vancouver
Franceschini SA, Vieira CS, Andozia MB, Tolloi MRT, Sá MFS de, Ferriani RA. In vivo and in vitro endothelial effects of the oral contraceptive containing 2mg chlormadinone acetate/0.3 mg ethinylestradiol. Human Reproduction. 2011 ; 26 i247-i248.[citado 2024 maio 26 ]